173 related articles for article (PubMed ID: 34125329)
1. Long non-coding RNA NKILA regulates expression of HSP90α, NF-κB and β-catenin proteins in the MCF-7 breast cancer cell line.
Tibatan MA; Önay Uçar E
Mol Biol Rep; 2021 May; 48(5):4563-4571. PubMed ID: 34125329
[TBL] [Abstract][Full Text] [Related]
2. NF-κB/NKILA signaling modulates the anti-cancerous effects of EZH2 inhibition.
Duan S; Chan WK; Oman A; Basile DP; Alvira CM; Buxton ILO; Iosef C
J Cell Mol Med; 2019 Sep; 23(9):6182-6192. PubMed ID: 31282094
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
Hu D; Zhong T; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer.
Wu W; Chen F; Cui X; Yang L; Chen J; Zhao J; Huang D; Liu J; Yang L; Zeng J; Zeng Z; Pan Y; Su F; Cai J; Ying Z; Zhao Q; Song E; Su S
Int J Cancer; 2018 Nov; 143(9):2213-2224. PubMed ID: 29761481
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway.
Lu Z; Li Y; Wang J; Che Y; Sun S; Huang J; Chen Z; He J
J Exp Clin Cancer Res; 2017 Apr; 36(1):54. PubMed ID: 28412955
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA NKILA protects against myocardial ischaemic injury by enhancing myocardin expression via suppressing the NF-κB signalling pathway.
Liu Q; Liu Z; Zhou LJ; Cui YL; Xu JM
Exp Cell Res; 2020 Feb; 387(2):111774. PubMed ID: 31838061
[TBL] [Abstract][Full Text] [Related]
8. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S
Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer.
Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323
[TBL] [Abstract][Full Text] [Related]
10. lncRNA-NKILA/NF-κB feedback loop modulates laryngeal cancer cell proliferation, invasion, and radioresistance.
Yang T; Li S; Liu J; Yin D; Yang X; Tang Q
Cancer Med; 2018 May; 7(5):2048-2063. PubMed ID: 29573243
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NKILA inhibits invasion and migration of osteosarcoma cells via NF-κB/Snail signaling pathway.
Zhang GD; Li Y; Liao GJ; Qiu HW
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4118-4125. PubMed ID: 31173281
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2.
Xiu DH; Liu GF; Yu SN; Li LY; Zhao GQ; Liu L; Li XF
J Exp Clin Cancer Res; 2019 Feb; 38(1):94. PubMed ID: 30791958
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y
Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNAs regulated NF-κB signaling in cancer metastasis: Micromanaging by not so small non-coding RNAs.
Ahmad S; Abbas M; Ullah MF; Aziz MH; Beylerli O; Alam MA; Syed MA; Uddin S; Ahmad A
Semin Cancer Biol; 2022 Oct; 85():155-163. PubMed ID: 34314819
[TBL] [Abstract][Full Text] [Related]
15. Active fraction of Polyrhachis vicina Rogers (AFPR) suppressed breast cancer growth and progression via regulating EGR1/lncRNA-NKILA/NF-κB axis.
Li DM; Zhong M; Su QB; Song FM; Xie TG; He JH; Wei J; Lu GS; Hu XX; Wei GN
Biomed Pharmacother; 2020 Mar; 123():109616. PubMed ID: 31881485
[TBL] [Abstract][Full Text] [Related]
16. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NKILA correlates with the malignant status and serves as a tumor-suppressive role in rectal cancer.
Tao F; Xu Y; Yang D; Tian B; Jia Y; Hou J; Dong M
J Cell Biochem; 2018 Dec; 119(12):9809-9816. PubMed ID: 30171719
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57
Qiao E; Chen D; Li Q; Feng W; Yu X; Zhang X; Xia L; Jin J; Yang H
J Cell Biochem; 2019 Mar; 120(3):3978-3988. PubMed ID: 30378143
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Silencing of Tumor Suppressor lncRNA
Zhang MY; Calin G; Deng MD; Au-Yeung RKH; Wang LQ; Chim CS
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052468
[TBL] [Abstract][Full Text] [Related]
20. TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling.
Lu Z; Chen Z; Li Y; Wang J; Zhang Z; Che Y; Huang J; Sun S; Mao S; Lei Y; Gao Y; He J
J Mol Med (Berl); 2018 Apr; 96(3-4):301-313. PubMed ID: 29379981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
